Category Archives: Defective Drugs

Filing a class action suit against large companies such as pharmaceutical companies greatly improved the plaintiffs’ odds of reaching a settlement because it allows all of the plaintiffs to work together, pooling resources and sharing evidence.

When Does the FDA Recall Drugs?

The FDA will recall drugs if the drug has become more risky than helpful. When it becomes clear that a drug is unsafe or has dangerous side effects it will be taken off the market. Unfortunately, some drugs harmful qualities are not apparent until the drug is out in the world. Because of this, the FDA is responsible for monitoring these products and ensuring their safety. How Do Recalls Vary? The most common recalls happen due to a drug having dangerous side effects, but there are other events that can instigate a recall. For example, if the FDA finds a safer version of a drug it will recall the more harmful one. Consumers abusing a drug to the point of injury or death may also be reason enough for a recall. Recalls are categorized by how hazardous the drug’s threats are. The following are different groups of recalls. Class I…
Read More »

Posted in Defective Drugs, Personal Injury | Tagged , | Leave a comment

Could this Nausea Medication Be Causing Birth Defects?

A group of families have taken legal action against the makers of Zofran after the company didn’t provide enough warning that their product can cause birth defects. According to the accusers, the company that manufactures the drug, GlaxoSmithKline (GSK), did not warn consumers about the risks despite being aware of them early on. After outside studies showed that the popular anti-nausea medication caused cardiovascular and cleft-palate birth defects, GSK added a warning on the product. Early labels, however, did not include this information. Some believe that the company intentionally withheld the information from its customers. Additionally, the drug was never approved by the U.S. Food and Drug Administration for treating pregnant mothers. Initially, the medication was only approved for patients suffering from the nausea caused by cancer treatments such as chemotherapy. According to the lawsuit, GSK still marketed the drug to pregnant women, even though the FDA had never approved…
Read More »

Posted in Defective Drugs | Tagged | Leave a comment

NJ Birth Injury Lawsuit Alleges Zofran Caused Child’s Clubfoot

Yet another lawsuit has been filed against GlaxoSmithKline (GSK) after their drug, Zofran, caused the son of a New Jersey family to be born with a congenital defect. The birth injury lawsuit, which was originally filed in the U.S. District Court for the District of New Jersey, will be moved to the District of Massachusetts where it will be combined with over 230 other lawsuits related to Zofran into MDL 2657. How Did Zofran Cause the Birth Defect? According to the lawsuit, the mother in this case took every precaution to ensure that she would give birth to a healthy baby, including taking prenatal vitamins at least six months prior to becoming pregnant and abstaining from caffeine, alcohol, tobacco and other harmful products during pregnancy. When she did become pregnant, she was diagnosed with hyperemesis gravidarum, which is a condition common to pregnant mothers that causes extreme nausea. The condition…
Read More »

Posted in Defective Drugs | Tagged , | Leave a comment